| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | MEDIVATION INC | 4,397,838 | 265,190,000 | 85.95% | ||
| 2 | CORBUS PHARMACEUTICALS HLDGS COM | 2,563,925 | 7,666,000 | 2.48% | ||
| 3 | SYNTHETIC BIOLOGICS INC | 3,734,149 | 6,721,000 | 2.18% | ||
| 4 | ALCOBRA LTD | 1,115,315 | 5,008,000 | 1.62% | ||
| 5 | AMPIO PHARMACEUTICALS INC | 3,238,322 | 4,177,000 | 1.35% | ||
| 6 | Vascular Biogenics Ltd | 860,605 | 3,967,000 | 1.29% | ||
| 7 | ABEONA THERAPEUTICS INC | 1,359,767 | 3,209,000 | 1.04% | ||
| 8 | CEMPRA INC | 180,800 | 2,981,000 | 0.97% | ||
| 9 | Advaxis Inc. | 275,000 | 2,225,000 | 0.72% | ||
| 10 | VOLITIONRX LTD | 461,538 | 1,454,000 | 0.47% | ||
| 11 | KERYX BIOPHARMACEUTICALS INCORPORATED | 200,000 | 1,324,000 | 0.43% | ||
| 12 | NEWLINK GENETICS CORP | 102,437 | 1,153,000 | 0.37% | ||
| 13 | ALDEYRA THERAPEUTICS INC | 135,800 | 773,000 | 0.25% | ||
| 14 | OHR PHARMACEUTICAL INC | 205,000 | 562,000 | 0.18% | ||
| 15 | Advaxis Inc. | 112,500 | 502,000 | 0.16% | ||
| 16 | BIOBLAST PHARMA LTD | 250,970 | 402,000 | 0.13% | ||
| 17 | Evoke Pharma Inc | 55,660 | 381,000 | 0.12% | ||
| 18 | Caladrius Biosciences Inc | 555,781 | 328,000 | 0.11% | ||
| 19 | CHAMPIONS ONCOLOGY INC | 111,111 | 239,000 | 0.08% | ||
| 20 | Galmed Pharmaceuticals Ltd | 49,947 | 224,000 | 0.07% | ||
| 21 | Aptose Biosciences Inc Com New | 11,933 | 29,000 | 0.01% | ||
| 22 | Zosano Pharma Corp | 11,195 | 15,000 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-119396, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
